{"id":20810,"date":"2015-08-04T17:55:49","date_gmt":"2015-08-04T15:55:49","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=20810"},"modified":"2015-08-04T18:04:12","modified_gmt":"2015-08-04T16:04:12","slug":"compra-in-india-il-farmaco-contro-lepatite-c-costa-700-euro-in-italia-74mila-euro","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/compra-in-india-il-farmaco-contro-lepatite-c-costa-700-euro-in-italia-74mila-euro\/","title":{"rendered":"Buy the drug against hepatitis C in India: \u00abIt costs 700 euros, in Italy 74 thousand euros\u00bb"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" src=\"http:\/\/pharmastar.it\/binary_files\/news\/gilead_14301.jpg\" alt=\"\" width=\"281\" height=\"187\" \/>NEW DELHI - Marco, a 40-year-old from Trentino, has hepatitis C. In Italy, the drug to treat the disease is expensive <strong>74 thousand euros<\/strong>, too high a figure for man. So Marco decides to go and buy medicine in India, where it is expensive <strong>700 euros<\/strong>. A more affordable figure that can change his life.<\/p>\n<p>As reported by the newspaper <strong>The Republic<\/strong>, that of the 40-year-old from Trentino would be the first Italian case of health tourism. Form of tourism denounced by the National Patients&#039; Court: &quot;While the institutions decide whether and how to treat more people, Italian hepatitis C patients go to India, or to Hong Kong to get medicines at affordable prices&quot;.<\/p>\n<p>The drug consists of the molecule <strong>sofosbuvir<\/strong>, developed by the American pharmaceutical company <strong>Gilead<\/strong> and ensures a cure in 90-95% of cases.<\/p>\n<p>As Repubblica reports, the problem with medicine is that the price to the public is 74 thousand euros. Enough to make the national health system break the bank, which last year admitted the drug into public facilities at the &quot;subsidized&quot; price of <strong>37 thousand euros<\/strong>. But only for the most serious cases.<\/p>\n<p>Marco, on the other hand, is at the beginning of the disease. And he found himself <strong>last on the waiting list<\/strong>. For this reason he decided to fly to India.<\/p>\n<p><a href=\"http:\/\/www.ilmattino.it\/PRIMOPIANO\/CRONACA\/marco_va_in_india_per_comprare_farmaco_contro_epatite_c_in_italia_costa_74mila_euro\/notizie\/1500202.shtml\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Tuesday 4 August 2015 \u2013 il Mattino.it<\/span><\/a><\/p>\n<p><img decoding=\"async\" class=\"aligncenter\" src=\"http:\/\/trentinocorrierealpi.gelocal.it\/polopoly_fs\/1.11879990.1438632598!\/httpImage\/image.jpg_gen\/derivatives\/detail_558\/image.jpg\" alt=\"\" \/><\/p>\n<p>Related news: <a href=\"http:\/\/trentinocorrierealpi.gelocal.it\/trento\/cronaca\/2015\/08\/04\/news\/farmaci-troppo-costosi-vado-in-india-1.11879970\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">\u201cDrugs too expensive? I&#039;m going to India&quot;<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>NEW DELHI &#8211; Marco, 40enne trentino, ha l&#8217;epatite C. In Italia il farmaco per curare la malattia costa 74mila euro, una cifra troppo alta per l&#8217;uomo. Cos\u00ec Marco decide di andare a comprare la medicina in India, dove costa 700 euro. Una cifra pi\u00f9 abbordabile e che pu\u00f2 cambiargli la vita. Come riporta il quotidiano &hellip;<\/p>","protected":false},"author":4,"featured_media":7277,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[29],"class_list":["post-20810","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-prezzo-farmaci"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/20810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=20810"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/20810\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/7277"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=20810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=20810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=20810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}